Evidence map›Paper›PMID 25379508›Full record

ReviewBioMed research international2014

Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.

Xuanbin Wang, Yibin Feng, Ning Wang, Fan Cheung, Hor Yue Tan, Sen Zhong, Charlie Li, Seiichi Kobayashi

Abstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Retrospection ofMini reviews in medicinal chemistry · 2026
    Review
  2. An In-depth Review onAnti-cancer agents in medicinal chemistry · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Chloroform fraction ofOncology letters · 2018
    Article
  14. Article
  15. Aloe-Emodin Influence on the Lysosomal Compartment of Hela CellsAsian Pacific journal of cancer prevention : APJCP · 2017
    Article
  16. Chloroform extract ofOncology letters · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xuanbin WangSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong ; Laboratory of Chinese Herbal Pharmacology, Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine, Shiyan, Hubei 442000, China.
Yibin FengSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong.ORCID 0000-0002-0241-670X
Ning WangSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong.ORCID 0000-0003-1410-329X
Fan CheungSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong.ORCID 0000-0003-1989-6911
Hor Yue TanSchool of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong.
Sen ZhongLaboratory of Chinese Herbal Pharmacology, Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine, Shiyan, Hubei 442000, China.
Charlie LiCalifornia Department of Public Health, 850 Marina Bay Parkway, G365, Richmond, CA 94804, USA.ORCID 0000-0002-6792-1643
Seiichi KobayashiFaculty of Healthy Science, Hokkaido University, Kita 15, Nishi 7 Kita-ku, Sapporo, Japan.ORCID 0000-0002-5867-6076

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese medicines have long history in treating cancer. With the growing scientific evidence of biomedical researches and clinical trials in cancer therapy, they are increasingly accepted as a complementary and alternative treatment. One of the mechanisms is to induce cancer cell death. Aim. To comprehensively review the publications concerning cancer cell death induced by Chinese medicines in recent years and provide insights on anticancer drug discovery from Chinese medicines. Materials and Methods. Chinese medicines (including Chinese medicinal herbs, animal parts, and minerals) were used in the study. The key words including "cancer", "cell death", "apoptosis", "autophagy," "necrosis," and "Chinese medicine" were used in retrieval of related information from PubMed and other databases. Results. The cell death induced by Chinese medicines is described as apoptotic, autophagic, or necrotic cell death and other types with an emphasis on their mechanisms of anticancer action. The relationship among different types of cell death induced by Chinese medicines is critically reviewed and discussed. Conclusions. This review summarizes that CMs treatment could induce multiple pathways leading to cancer cell death, in which apoptosis is the dominant type. To apply these preclinical researches to clinic application will be a key issue in the future.

Indexed as

PhytotherapyAnimalsCell DeathDrug DiscoveryDrugs, Chinese HerbalHumansMedicine, Chinese TraditionalNeoplasmsDrugs, Chinese Herbal

Identifiers

PMID25379508
PMCPMC4212527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.